|
1.
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
2.
|
Bast RC Jr, Hennessy B and Mills GB: The
biology of ovarian cancer: new opportunities for translation. Nat
Rev Cancer. 9:415–428. 1996. View
Article : Google Scholar
|
|
3.
|
Bowtell DD: The genesis and evolution of
high-grade serous ovarian cancer. Nat Rev Cancer. 10:803–808. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Vaughan S, Coward JI, Bast RC Jr, Berchuck
A, Berek JS, Brenton JD, Coukos G, Crum CC, Drapkin R,
Etemadmoghadam D, Friedlander M, Gabra H, Kaye SB, Lord CJ, Lengyel
E, Levine DA, McNeish IA, Menon U, Mills GB, Nephew KP, Oza AM,
Sood AK, Stronach EA, Walczak H, Bowtell DD and Balkwill FR:
Rethinking ovarian cancer: recommendations for improving outcomes.
Nat Rev Cancer. 11:719–725. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Csukai M and Mochly-Rosen D: Pharmacologic
modulation of protein kinase C isozymes: the role of RACKs and
subcellular localisation. Pharmacol Res. 39:253–259. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Calura E, Cagnin S, Raffaello A, Laveder
P, Lanfranchi G and Romualdi C: Meta-analysis of expression
signatures of muscle atrophy. Gene interaction networks in early
and late stages. BMC Genomics. 9:6302008. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Robles MS, Boyault C, Knutti D,
Padmanabhan K and Weitz CJ: Identification of RACK1 and protein
kinase C as integral components of the mammalian circadian clock.
Science. 327:463–466. 2010. View Article : Google Scholar
|
|
8.
|
Li CL, Toda K, Saibara T, Zhang T, Ono M,
Iwasaki S, Maeda T, Okada T, Hayashi Y, Enzan H, Shizuta Y and
Onishi S: Estrogen deficiency results in enhanced expression of
smoothened of the Hedgehog signaling in the thymus and affects
thymocyte development. Int Immunopharmacol. 2:823–833.
2003.PubMed/NCBI
|
|
9.
|
Bible KC, Suman VJ, Molina JR, Smallridge
RC, Maples WJ, Menefee ME, Rubin J, Sideras K, Morris JC III,
McIver B, Burton JK, Webster KP, Bieber C, Traynor AM, Flynn PJ,
Goh BC, Tang H, Ivy SP and Erlichman C: Efficacy of pazopanib in
progressive, radioiodine-refractory, metastatic differentiated
thyroid cancers. Results of a phase 2 consortium study Lancet
Oncol. 11:962–972. 2010.PubMed/NCBI
|
|
10.
|
Toftgard R: Hedgehog signaling in cancer.
Cell Mol Life Sci. 57:1720–1731. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Gialmanidis IP, Bravou V, Amanetopoulou
SG, Varakis J, Kourea H and Papadaki H: Overexpression of hedgehog
pathway molecules and FOXM1 in non-small-cell lung carcinomas. Lung
Cancer. 66:64–74. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Kadrmas JL, Smith MA and Pronovost SM:
Characterization of RACK1 function in Drosophila
development. Dev Dyn. 236:2207–2215. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Mor I, Sklan EH, Podoly E, Pick M,
Kirschner M, Yogev L, Bar-Sheshet Itach S, Schreiber L, Geyer B,
Mor T, Grisaru D and Soreq H: Acetylcholinesterase-R increases germ
cell apoptosis but enhances sperm motility. J Cell Mol Med.
12:479–495. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Battaini F, Pascale A, Paoletti R and
Govoni S: The role of anchoring protein RACK1 in PKC activation in
the ageing rat brain. Trends Neurosci. 20:410–415. 1997. View Article : Google Scholar
|
|
15.
|
Qiu Y, Mao T, Zhang Y, Shao M, You J, Ding
Q, Chen Y, Wu D, Xie D, Lin X, Gao X, Kaufman RJ, Li W and Liu Y: A
crucial role for RACK1 in the regulation of glucose-stimulated IRE1
activation in pancreatic cells. Sci Signal. 3:ra72010.PubMed/NCBI
|
|
16.
|
Shi S, Deng YZ, Zhao JS, Ji XD, Shi J,
Feng YX, Li G, Li JJ, Zhu D, Koeffler HP, Zhao Y and Xie D: Sonic
Hedgehog signaling pathway cancer tumorigenicity through activating
RACK1 promotes non-small-cell lung. J Biol Chem. 287:7845–7858.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Wang F, Osawa T, Tsuchida R, Yuasa Y and
Shibuya M: Downregulation of receptor for activated C-kinase 1
(RACK1) suppresses tumor growth by inhibiting tumor cell
proliferation and tumor-associated angiogenesis. Cancer Sci.
102:2007–2013. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Cao XX, Xu JD, Xu JW, Liu XL, Cheng YY,
Wang WJ, Li QQ, Chen Q, Xu ZD and Liu XP: RACK1 promotes breast
carcinoma proliferation and invasion/metastasis in vitro and in
vivo. Breast Cancer Res Treat. 123:375–386. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Zhang W, Zong CS, Hermanto U,
Lopez-Bergami P, Ronai Z and Wang LH: RACK1 recruits STAT3
specifically to insulin and insulin-like growth factor 1 receptors
for activation, which is important for regulating anchorage
independent growth. Mol Cell Biol. 26:413–424. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Campo E, Merino MJ, Liotta L, Neumann R
and Stetler-Stevenson W: Distribution of 72-kd type IV collagenase
in nonneoplastic and neoplastic thyroid tissue. Hum Pathol.
23:1395–1401. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Coleman JE, Huentelman MJ, Kasparov S,
Metcalfe BL, Paton JF, Katovich MJ, Semple-Rowland SL and Raizada
MK: Efficient large-scale production and concentration of
HIV-1-based lentiviral vectors for use in vivo. Physiol Genomics.
12:221–228. 2003.PubMed/NCBI
|
|
22.
|
Ron D, Chen CH, Caldwell J, Jamieson L,
Orr E and Mochly-Rosen D: Cloning of an intracellular receptor for
protein kinase C: a homolog of the beta subunit of G proteins. Proc
Natl Acad Sci USA. 91:839–843. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Ron D and Mochly-Rosen D: Agonists and
antagonists of protein kinase C function, derived from its binding
proteins. J Biol Chem. 269:21395–21398. 1994.PubMed/NCBI
|
|
24.
|
Liliental J and Chang DD: Rack1: a
receptor for activated protein kinase C, interacts with integrin
beta subunit. J Biol Chem. 273:2379–2383. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Wang F, Yamauchi M, Muramatsu M, Osawa T,
Tsuchida R and Shibuya M: RACK1 regulates VEGF/Flt1-mediated cell
migration via activation of a PI3K/Akt pathway. J Biol Chem.
286:9097–9106. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Wang F, Yamauchi M, Muramatsu M, Osawa T,
Tsuchida R and Shibuya M: The interaction of Src and RACK1 is
enhanced by activation of protein kinase C and tyrosine
phosphorylation of RACK1. J Biol Chem. 276:20346–20356. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Besson A, Wilson TL and Yong VW: The
anchoring protein RACK1 links protein kinase C epsilon to integrin
beta chains. Requirements for adhesion and motility. J Biol Chem.
277:22073–22084. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Bourd-Boittin K, LePabic H and Bonnier D:
RACK1, a new ADAM12 interacting protein. Contribution to liver
fibrogenesis J Biol Chem. 283:26000–26009. 2008.PubMed/NCBI
|
|
29.
|
Egidy G, Jule S and Bosse P: Transcription
analysis in the MeLiM swine model identifies RACK1 as a potential
marker of malignancy for human melanocytic proliferation. Mol
Cancer. 7:342008. View Article : Google Scholar
|
|
30.
|
Berns H, Humar R, Hengerer B, Kiefer FN
and Battegay EJ: RACK1 is upregulated in angiogenesis and human
carcinomas. FASEB J. 14:2549–2558. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Schechtman D and Mochly-Rosen D: Adaptor
proteins in protein kinase C mediated signal transduction.
Oncogene. 20:6339–6347. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Kiely PA, Sant A and O’Connor R: RACK1 is
an insulin-like growth factor 1 (IGF-1) receptor-interacting
protein that can regulate IGF-1-mediated Akt activation and
protection from cell death. J Biol Chem. 277:22581–22589. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Kraus S, Gioeli D, Vomastek T, Gordon V
and Weber MJ: Receptor for activated C kinase 1 (RACK1) and Src
regulate the tyrosine phosphorylation and function of the androgen
receptor. Cancer Res. 66:11047–11054. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Hermanto U, Zong CS, Li W and Wang LH:
RACK1, an insulin-like growth factor I (IGF-I) receptor-interacting
protein, modulates IGF-I-dependent integrin signaling and promotes
cell spreading and contact with extracellular matrix. Mol Cell
Biol. 22:2345–2365. 2002. View Article : Google Scholar
|
|
35.
|
Falasca M: PI3K/Akt signalling pathway
specific inhibitors: a novel strategy to sensitize cancer cells to
anti-cancer drugs. Curr Pharm Des. 16:1410–1416. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Katz M, Amit I and Yarden Y: Regulation of
MAPKs by growth factors and receptor tyrosine kinases. Biochim
Biophys Acta. 1773:1161–1176. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Mamidipudi V, Dhillon NK, Parman T, Miller
LD, Lee KC and Cartwright CA: RACK1 inhibits colonic cell growth by
regulating Src activity at cell cycle checkpoints. Oncogene.
26:2914–2924. 2007. View Article : Google Scholar : PubMed/NCBI
|
